Abstract:microRNA plays an important role in the development of tumors, including osteosarcoma. However, the role of miR-1225-5p in osteosarcoma is currently unclear. First, we found that miR-1225-5p was downregulated in osteosarcoma cells relative to its levels in normal bone tissue by analyzing GSE28423 data in the GEO database. Using GSE39040, we found that low miR-1225-5p expression is associated with poor prognosis in patients with osteosarcoma, and we also found low miR-1225-5p expression in patients with recurrent osteosarcoma. We later demonstrated that osteosarcoma cell lines transfected with miR-1225-5p mimic had decreased ability to proliferate, migrate, and invade relative to control cells. To elucidate the mechanism by which miR-1225-5p inhibits the development of osteosarcoma, we identified Sox9 as a target gene of miR-1225-5p using the TargetScan website. We confirmed that Sox9 is the target gene of miR-1225-5p using the luciferase reporter assay. We then found that Sox9 is highly expressed in osteosarcoma by analyzing the GSE16088 and GSE42352 datasets and that high expression of Sox9 is associated with poor prognosis in patients with osteosarcoma using the R2 database. Further analysis using the TARGET database uncovered that high Sox9 expression is associated with a high recurrence rate in patients with osteosarcoma. Transfection of Sox9 siRNA inhibited the proliferation, migration, and invasiveness of osteosarcoma cells. We transfected miR-1225-5p together with Sox9 siRNA into osteosarcoma cells, observing strong inhibition of proliferation, migration, and invasiveness. Finally, exogenous expression of Sox9 partially reversed the anticancer effects of miR-1225-5p in osteosarcoma cells. Taken together, our findings suggest that miR-1225-5p functions as a tumor suppressor in osteosarcoma by targeting Sox9, thereby revealing new therapeutic targets for osteosarcoma.

MiR‐409‐3p regulates cell proliferation and tumor growth by targeting E74‐like factor 2 in osteosarcoma

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Tumor-Suppressing Effects of Mir-429 on Human Osteosarcoma

Regulation of Osteosarcoma Proliferation and Apoptosis by Mir-489 Through Targeting Sox4 Gene

Mir-34c-3p Acts As A Tumor Suppressor Gene in Osteosarcoma by Targeting Marcks

miR-1225-5p Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox9

miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2

MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration

MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression

Mir-874 Suppresses the Proliferation and Metastasis of Osteosarcoma by Targeting E2f3

MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma

Mir-218 Suppresses the Proliferation of Osteosarcoma Through Downregulation of E2F2

Mir-574-3p Acts As a Tumor Promoter in Osteosarcoma by Targeting SMAD4 Signaling Pathway

MiR-181a Promotes the Proliferation and Metastasis of Osteosarcoma Cells by Targeting RASSF1A

MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27.

Microrna-194 Suppresses Osteosarcoma Cell Proliferation and Metastasis in Vitro and in Vivo by Targeting CDH2 and IGF1R.

Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.

Microrna-200b Acts As a Tumor Suppressor in Osteosarcoma Via Targeting ZeB1

MiR-223/Ect2/p21 Signaling Regulates Osteosarcoma Cell Cycle Progression and Proliferation.